Major Paroxetine Companies in South Korea | Leaders 2026

Major Paroxetine Companies in South Korea

The following is a data-backed list of the leading South Korea Paroxetine companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the South Korea Paroxetine Industry, including Janssen Korea (Johnson & Johnson), Hanmi Pharmaceutical Co., Ltd., and other established names.

List of Paroxetine companies in South Korea:

1. Janssen Korea (Johnson & Johnson)

Leveraging global expertise in neuroscience, Janssen provides high-quality psychiatric medications and leads in clinical research initiatives.

2. Hanmi Pharmaceutical Co., Ltd.

Hanmi utilizes advanced R&D to produce highly efficacious generic formulations that are widely prescribed in national hospitals.

3. Daewoong Pharmaceutical Co., Ltd.

Daewoong maintains a formidable presence in the domestic market through high-tech manufacturing standards.

4. Yuhan Corporation

Yuhan ensures stable distribution of essential psychiatric drugs through extensive pharmacy networks.

5. Chong Kun Dang Pharmaceutical Corp.

A key player in the CNS segment, providing cost-effective, high-quality psychiatric solutions that support diverse patient needs.

6. Dong-A ST Co., Ltd.

Dong-A ST maintains a strong portfolio in psychiatric medicines, combining legacy expertise with modern quality management systems.

7. HK inno.N Corporation

HK inno.N is a specialized manufacturer focusing on high-potency, stable drug delivery systems for patients with chronic mental health conditions.

8. Boryung Pharmaceutical Co., Ltd.

Boryung plays a vital role in meeting public health demand for SSRIs.

9. JW Pharmaceutical Corporation

JW provides high-quality psychiatric solutions, particularly focusing on hospital-based care and clinical therapeutic excellence.

10. GC Biopharma (Green Cross)

GC Biopharma is a specialized manufacturer committed to the highest quality benchmarks for psychiatric treatments.

Frequently Asked Questions About the Market Study (FAQs):